Search Results 381-390 of 18385 for total bilirubin

1. Atorvastatin and ezetimibe (oral route) - Side effects & dosage - Mayo Clinic

   Swallow the tablet whole. Do not crush, break, chew, or dissolve it. You may take this medicine with or without food. If you are taking certain medicines to ...

2. Genetically Engineered Cells (MUC1-Activated T-Cells) for the Treatment of MUC1 Positive Recurrent or Refractory Multiple Myeloma - Mayo Clinic

   ... total Bilirubin is ≤3.0 x ULN and direct bilirubin ≤1.5 x ULN); Alanine aminotransferase (ALT) and aspartate transaminase (AST) £3 x ULN (≤5 x ULN for ...

3. Imetelstat Sodium in Treating Patients with Primary or Secondary Myelofibrosis - Mayo Clinic

   Total bilirubin ≤ 3.0 mg/dL (or direct bilirubin < 1 mg/dL); Creatinine ≤ 3.0 mg/dL; Absolute neutrophil count ≥ 1000/uL; Platelet count ≥ 50,000/uL ...

4. A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Advanced Gastrointestinal Cancer - Mayo Clinic

   Total bilirubin level ≤1.5 × ULN. Creatinine ≤1.5 x ULN or creatinine clearance >60 mL/min/1.73 m2 for patients with creatinine levels above institutional ...

5. A Study To Evaluate The Effects Of Two Doses Of MBX-8025 In Subjects With Primary Biliary Cirrhosis - Mayo Clinic

   Total bilirubin > 2 × ULN; Auto-immune hepatitis; Primary sclerosing ... Serum creatinine above ULN; For females, pregnancy or breast-feeding; Use of ...

6. PRGN-3006 Adoptive Cellular Therapy for CD33-Positive Relapsed or Refractory AML, MRD Positive AML or Higher Risk MDS - Mayo Clinic

   - Bilirubin ≤ 2.0 mg/dL or total bilirubin ≤ 3.0 x ULN with direct bilirubin within normal range in participants with well documented Gilbert's syndrome ...

7. Ibrutinib in Treating Minimal Residual Disease in Patients With Chronic Lymphocytic Leukemia After Front-Line Therapy - Mayo Clinic

   Total bilirubin =< 1.5 mg/dL or direct bilirubin =< 1.0 mg/dL for patients ... Serum glutamic oxaloacetic transaminase (SGOT) (aspartate aminotransferase [AST]) ...

8. Emricasan, A Caspase Inhibitor, For Evaluation In Subjects With Non-Alcoholic Steatohepatitis (NASH) Fibrosis - Mayo Clinic

   ... bilirubin >1.5 times ULN during screening (unless subject has elevated total bilirubin due to Gilbert's as documented in the medical records); Alpha ...

9. A Study Using Chemotherapy Followed by Radiation Therapy in Treating Younger Patients with Newly Diagnosed Localized Central Nervous System Germ Cell Tumors - Mayo Clinic

   Total bilirubin ≤ 1.5 times upper limit of normal (ULN); Serum glutamic oxaloacetic transaminase (SGOT) (aspartate aminotransferase [AST]) or serum glutamic ...

10. Phase III Study to Evaluate the Efficacy and Safety of the INTERCEPT Blood System for Red Blood Cells in Patients Undergoing Complex Cardiac Surgery Procedures - Mayo Clinic

    with a total serum bilirubin ≥ 2.0 mg/dL (≥34.2 µmol/L). (NOTE: If total serum bilirubin at screening is <2.0 mg/dL, a patient with a diagnosis of chronic or ...